LPL Financial
AVDL

LPL Financial’s Avadel Pharmaceuticals AVDL Stock Holding History

LPL Financial’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-17,915
Closed -$386K – 5977
2025
Q4 		$386K Sell
17,915
-12,893
-42% -$250K ﹤0.01% 4950
2025
Q3 		$470K Sell
30,808
-8,131
-21% -$106K ﹤0.01% 4682
2025
Q2 		$345K Buy
38,939
+3,277
+9% +$28.8K ﹤0.01% 4676
2025
Q1 		$279K Buy
35,662
+1,537
+5% +$12.9K ﹤0.01% 4629
2024
Q4 		$359K Buy
34,125
+10,072
+42% +$122K ﹤0.01% 4366
2024
Q3 		$315K Sell
24,053
-519
-2% -$7.91K ﹤0.01% 4386
2024
Q2 		$345K Sell
24,572
-1,175
-5% -$19.2K ﹤0.01% 4162
2024
Q1 		$435K Buy
25,747
+2,190
+9% +$32.6K ﹤0.01% 3896
2023
Q4 		$333K Buy
23,557
+3,427
+17% +$40.3K ﹤0.01% 4011
2023
Q3 		$207K Sell
20,130
-278
-1% -$3.72K ﹤0.01% 4206
2023
Q2 		$336K Buy
20,408
+4,958
+32% +$64.5K ﹤0.01% 3753
2023
Q1 		$142K Sell
15,450
-13,000
-46% -$107K ﹤0.01% 4137
2022
Q4 		$204K Hold
28,450
– – ﹤0.01% 3970
2022
Q3 		$143K Sell
28,450
-2,400
-8% -$13.2K ﹤0.01% 4031
2022
Q2 		$75K Buy
30,850
+8,900
+41% +$36.5K ﹤0.01% 4182
2022
Q1 		$150K Buy
21,950
+2,400
+12% +$16.5K ﹤0.01% 3900
2021
Q4 		$158K Buy
19,550
+600
+3% +$5.48K ﹤0.01% 4040
2021
Q3 		$186K Sell
18,950
-200
-1% -$1.57K ﹤0.01% 4010
2021
Q2 		$129K Buy
19,150
+3,000
+19% +$23.8K ﹤0.01% 4009
2021
Q1 		$146K Buy
16,150
+5,900
+58% +$47.7K ﹤0.01% 3857
2020
Q4 		$68K Sell
10,250
-800
-7% -$5K ﹤0.01% 3714
2020
Q3 		$56K Sell
11,050
-2,133
-16% -$15.5K ﹤0.01% 3426
2020
Q2 		$107K Buy
+13,183
New +$116K ﹤0.01% 3283

Other funds holding AVDL

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

LPL Financial's AVDL Position: Q1 2026 in Review

LPL Financial sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 17,915 shares — an estimated $386K sold.

LPL Financial first reported a position in AVDL in Q2 2020 and held it in 23 quarters. The position peaked at $470K in Q3 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

  • LPL Financial reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • LPL Financial sold 17,915 Avadel Pharmaceuticals shares in Q1 2026, an estimated $386K.
  • LPL Financial first reported a position in Avadel Pharmaceuticals in Q2 2020 and held it in 23 quarters.
  • LPL Financial's Avadel Pharmaceuticals position peaked at $470K in Q3 2025.
  • 2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.